
    
      The study is to evaluate the efficacy and safety of Sanhuangjingshimingwan,give two times a
      day versus placebo in wAMD .The clinical phase of the study comprises a 6-months double-blind
      treatment period, resulting in 6.5-months overall duration of the study for each patient.
    
  